Clinical trial
Long Term Effects of Enalapril and Losartan on Genetic Heart Disease
NCT00001534 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001534 |
|---|---|
| Title | Long Term Effects of Enalapril and Losartan on Genetic Heart Disease |
| Official title | Double-Blind, Placebo-Controlled Study of the Long Term Effects of Angiotensin Converting Enzyme Inhibition (Enalapril) and Angiotensin II Receptor Blockade (Losartan) on Genetically-Induced Left Ventricular Hypertrophy in Non-Obstructive HCM |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Hypertrophic Cardiomyopathy, Left Ventricular Hypertrophy, Myocardial Ischemia |
| Intervention type | Drug |
| Interventions | Losartan |
| Enrollment | 112 |
| Start date | Sep 1, 1996 |
| Completion | Apr 1, 2003 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: